Form 4: Herbalife Executive Henry C. Wang Reports Stock and SARs Transactions
SEC Form 4
EVP and General Counsel of Herbalife, Henry C. Wang, reports acquisition of restricted stock units and stock appreciation rights, along with tax-related disposals.
Summary
- Henry C. Wang, EVP and General Counsel of Herbalife, filed a Form 4 detailing changes in beneficial ownership.
- On May 3, 2024, Wang acquired 36,534 restricted stock units (RSUs) and 212,550 stock appreciation rights (SARs) under the Herbalife Ltd. 2023 Stock Incentive Plan.
- These RSUs and SARs will vest in one-third increments on May 3, 2025, May 3, 2026, and May 3, 2027, contingent upon continued service.
- On May 4, 2024, 4,348 shares were disposed of to cover tax obligations related to the vesting of RSUs granted on May 4, 2023, at a price of $9.58 per share.
- Wang also reported owning 213,673 shares of common stock, which includes 945 shares purchased through the Employee Stock Purchase Plan since the last Form 4 filing on March 27, 2024.
- Following these transactions, Wang beneficially owns 209,325 shares of common stock and 212,550 stock appreciation rights.
Sentiment
Score: 6
Explanation: The document reflects standard executive compensation practices. It's neutral in sentiment, indicating routine transactions rather than significant positive or negative developments.
Positives
- The grant of RSUs and SARs to a key executive like the General Counsel suggests a long-term incentive alignment with the company's performance.
- Continued participation in the Employee Stock Purchase Plan indicates confidence in Herbalife's future.
Negatives
- The disposal of shares to cover tax obligations, while routine, slightly reduces the executive's direct shareholding.
Risks
- The vesting of RSUs and SARs is contingent upon continued service, creating a potential risk if the executive were to leave the company before the vesting dates.
Future Outlook
The vesting schedule of the RSUs and SARs indicates a multi-year incentive plan for the executive, aligning their interests with the long-term performance of Herbalife.
Industry Context
Form 4 filings are standard practice for publicly traded companies and their executives, providing transparency into insider transactions. This filing is typical for executives receiving equity-based compensation.
Comparison to Industry Standards
- Equity compensation is a common practice among publicly traded companies to incentivize executives.
- Vesting schedules of three years are standard for RSU and SAR grants.
- The amount of equity granted is likely determined by Herbalife's compensation policies and benchmarking against peer companies.
Stakeholder Impact
- The transactions have a minor impact on shareholders, reflecting standard executive compensation practices.
- Employees may view the equity grants as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 03/27/2024 | Date of Reporting Person's last Form 4 filing |
| 05/03/2024 | Date of RSU and SARs grant |
| 05/04/2023 | Date of RSUs previously granted to the Reporting Person |
| 05/04/2024 | Date of shares withheld to satisfy tax obligations |
| 05/03/2025 | First vesting date for RSUs and SARs |
| 05/03/2026 | Second vesting date for RSUs and SARs |
| 05/03/2027 | Third vesting date for RSUs and SARs |
| 05/03/2034 | Expiration date for SARs |
| 05/07/2024 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.